Humoral hypercalcemia of malignancy in a patient with hypoparathyroidism

被引:0
|
作者
Krysiak, R. [1 ]
Handzlik-Orlik, G. [1 ]
Okopien, B. [1 ]
机构
[1] Med Univ Silesia, Dept Internal Med & Clin Pharmacol, Katowice, Poland
关键词
Hypercalcemia; Hypoparathyroidism; Lung cancer; Parathyroid hormone-related protein; Diagnosis and treatment;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
INTRODUCTION, Elevated plasma calcium level in patients diagnosed with primary hypoparathyroidism is a rare finding, resulting in most cases from the treatment with excessive doses of either vitamin D or its derivatives, or calcium salts. CASE, We report a case of a woman who developed severe hypercalcemia due to metastatic lung cancer, describing diagnostics strategies undertaken in this patient. Pamidronate treatment with subsequent chemotherapy resulted in a transient normalization of plasma calcium levels. CONCLUSION, Our report shows that the presence of malignancy should always be taken into consideration in hypoparathyroid patients in whom plasma calcium levels increase and that the assessment of plasma levels of parathyroid hormone related peptide may be helpful in the differential diagnosis of hypercalcemia.
引用
收藏
页码:1127 / 1129
页数:3
相关论文
共 50 条
  • [31] A Case of Fibroblast Growth Factor Receptor Fusion-Positive Intrahepatic Cholangiocarcinoma With Humoral Hypercalcemia of Malignancy
    Chauhan, Aditya
    Likasitwatanakul, Pornlada
    Ahmed, Ammar
    Sibley, Shalamar D.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [32] A PATIENT WITH PRIMARY HYPOPARATHYROIDISM DEVELOPING HYPERCALCEMIA ASSOCIATED WITH ADULT T-CELL LEUKEMIA/LYMPHOMA
    KONDO, S
    TAMURA, K
    MAKINO, S
    YOKOTA, T
    ISHIKAWA, E
    KATAKAMI, H
    KOHARI, S
    LEUKEMIA & LYMPHOMA, 1994, 14 (5-6) : 521 - 525
  • [33] Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy
    Onuma, E
    Sato, K
    Saito, H
    Tsunenari, T
    Ishii, K
    Esaki, K
    Yabuta, N
    Wakahara, Y
    Yamada-Okabe, H
    Ogata, E
    ANTICANCER RESEARCH, 2004, 24 (5A) : 2665 - 2673
  • [34] Hypercalcemia of malignancy: Epidemiology and pathogenesis
    Martin T.J.
    Clinical Reviews in Bone and Mineral Metabolism, 2002, 1 (1): : 51 - 63
  • [35] HYPERCALCEMIA OF MALIGNANCY - PATHOPHYSIOLOGY AND TREATMENT
    ADAMI, S
    ROSSINI, M
    BONE, 1992, 13 : S51 - S55
  • [36] Hypercalcemia of Malignancy and Acute Pancreatitis
    Imam, Zaid
    Hanna, Angy
    Jomaa, Diana
    Khasawneh, Majd
    Abonofal, Abdulrahman
    Murad, M. Hassan
    PANCREAS, 2021, 50 (02) : 206 - 213
  • [37] Conventional treatment of hypercalcemia of malignancy
    Davidson, TG
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (22) : S8 - S15
  • [38] Quality and Outcomes of Treatment of Hypercalcemia of Malignancy
    Wright, Jason D.
    Tergas, Ana I.
    Ananth, Cande V.
    Burke, William M.
    Hou, June Y.
    Chen, Ling
    Neugut, Alfred I.
    Richards, Catherine A.
    Hershman, Dawn L.
    CANCER INVESTIGATION, 2015, 33 (08) : 331 - 339
  • [39] Hypercalcemia of Malignancy: An Update on Pathogenesis and Management
    Mirrakhimov, Aibek E.
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2015, 7 (11) : 483 - 493
  • [40] Hypercalcemia of malignancy and new treatment options
    Sternlicht, Hillel
    Glezerman, Ilya G.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1779 - 1788